With 15 years of experience, he is a UK board-certified consultant in histopathology. He played a key role in validating PDL1 SP (142) in collaboration with the immunohistochemistry section at SSMC. Dr. Magdub teaches pathologists how to interpret PDL1 SP (142) in the Train the Trainer program organized by Roche Middle East. With expertise in histopathology and cytopathology, Dr. Magdub is a fellow of the Royal College of Pathologists (FRCPath), UK. He holds licenses from the General Medical Council (GMC), UK, and the Department of Health (DOH), UAE. His professional journey includes consultancy roles at Southmead Hospital, UK, and Tawam Hospital, UAE. His dedication to advancing pathology and patient care is reflected in his active involvement in clinical research and teaching initiatives.